|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 435 articles |
 Page 1 of 6 
|
Canadian govt brings back drug export bill.
February 23, 2004
"Let UK patients pay for statins:" BMJ report.
February 23, 2004
Risperdal Consta switch benefits young adults.
February 23, 2004
Riquent on track in USA.
February 23, 2004
Valeant buys Amarin unit in $38M deal.
February 23, 2004
Aventis appeals AMF decision on Sanofi bid.
February 23, 2004
Framework Grant award for Proteome Sciences.
February 23, 2004
Merck & Co to provide free medicines in certain situations.
February 23, 2004
Invitrogen prices $450M convertible notes.
February 23, 2004
Lilly completes acquisition of Applied Molecular.
February 23, 2004
Major pharma mergers "will not bring therapeutic progress".
February 23, 2004
Altana's Daxas filed for EU approval.
February 23, 2004
Agis denies deal with Barr but is considering merger options.
February 23, 2004
Demand from Japan drugmakers for human microdosing.
February 23, 2004
Novartis' Slovenian subsidiary Lek boosts biopharma activity.
February 23, 2004
Merck KGaA disposes of VWR lab distribution unit for $1.68B.
February 23, 2004
Swedish reimbursement review moves on.
February 23, 2004
Affitech gets FUGE grant for new cancer drug.
February 23, 2004
Novartis considering US acquisition?
February 23, 2004
Ukraine: concern at pharma imports.
February 23, 2004
French LEEM views govt drugs review.
February 23, 2004
Indian pharma "set to boom across the board".
February 23, 2004
Roche's Pegasys and Copegus effective in in HIV-HCV co-infected patien...
February 23, 2004
Abbott's Humira shows promise for psoriasis.
February 23, 2004
German call for clear drug promo rules.
February 23, 2004
HIV vacc trial in Germany.
February 23, 2004
Tokyo pharma stocks - week to Feb 16.
February 23, 2004
Merck KGaA erases debt with sale of VWR; reports organic growth of 7% ...
February 23, 2004
Generics "mistake" in Polish EU transition list?
February 23, 2004
Spanish drug prices.(Brief Article)
February 23, 2004
Sanofi-Synthelabo reveals R&D pipeline with nine compounds in Ph III.
February 23, 2004
Supervisory Board rejects Sanofi offer.(Aventis Pasteur S.A)(Sanofi-Sy...
February 23, 2004
Medeus acquires Elan business for $120M.
February 23, 2004
Antisoma reduces losses: awaits R1549.
February 23, 2004
Israeli govt views high prices of Euro drugs.
February 23, 2004
ImClone's Erbitux cleared by FDA.
February 23, 2004
Aventis files insulin delivery device.
February 23, 2004
Barr says FDA extends PDUFA deadline on Plan B.
February 23, 2004
Amersham and Bayer enter diagnostics deal.
February 23, 2004
GSK to progress 873140 for HIV.
February 23, 2004
Novartis completes US nutritionals buy.
February 23, 2004
US court dismisses Univ of Rochester Celebrex patent case.(Brief Artic...
February 23, 2004
French generics market up 34% in 2003.(Brief Article)
February 23, 2004
Switzerland to raise pharma tax.(Brief Article)
February 23, 2004
Awareness and understanding of IBS key to promote new drugs.
February 23, 2004
Endo net sales surge 49% in 2003.
February 23, 2004
Tinidazole gets FDA Orphan Drug status.
February 23, 2004
Lilly says Zyprexa superior to rivals in schizophrenia relapse-prevent...
February 23, 2004
UK NICE to publish impact report in April.
February 23, 2004
Israel studies worldwide politics of pharmaceutical reimbursement.
February 23, 2004
Sanofi-Synthelabo remains confident on Aventis buy; reports strong fin...
February 23, 2004
Taro Pharma sees strong 4th-qtr 2003 growth.(Brief Article)
February 23, 2004
Putin pledge to Russian pharma industry.(Vladimir Putin )(Brief Articl...
February 23, 2004
Hungarian pharma production, sales data.(Brief Article)
February 23, 2004
Vivus licenses two products from Acrux.
February 23, 2004
GSK results in line with company guidance; shares fall on 16% drop in ...
February 23, 2004
Modest profit growth for Merck KGaA.
February 23, 2004
Israeli Rx import safety fears: funds and hospitals must take responsi...
February 23, 2004
Appeals court upholds dismissal of law suit over Pfizer's Zoloft.
February 23, 2004
Sanofi-Synthelabo results in line with expectations.
February 23, 2004
UPDATE: ImClone's Erbitux cleared by FDA.
February 23, 2004
Guilford reduces losses slightly.(Guilford Pharmaceuticals Inc.)(Brief...
February 23, 2004
aaiPharma shareholder action.
February 23, 2004
US Rx drug sales up 11.5% in 2003, growth sustained by new products, s...
February 23, 2004
Aventis and Intercell enter vaccine deal.(Brief Article)
February 23, 2004
Elan reports 34% drop in 2003 turnover.(Brief Article)
February 23, 2004
SPECTRUM.(Brief Article)(Illustration)
February 23, 2004
Stock Commentary - Europe.(Brief Article)
February 23, 2004
Merck KGaA names new divisional heads.(Henryk Klakurka appointed to Ge...
February 23, 2004
Promising new data for CollaGenex' Periostat.(CollaGenex Pharmaceutica...
February 23, 2004
MS-325 filing accepted by FDA.(gadofosveset, gadolinium-based magnetic...
February 23, 2004
Rino Rappuoli becomes CSO at Chiron.(Brief Article)
February 23, 2004
Altana Canada names Alan Davis VP of clinical and scientific affairs.(...
February 23, 2004
Takeda and Oxford University open diabetes R&D unit.(Brief Article)
February 23, 2004
Seamus Mulligan steps down from Elan.(Brief Article)
February 23, 2004
|
1